📰 Ability Pharmaceuticals News
Ability Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ability Pharmaceuticals. Real-time updates on events, politics, business and more.
March 11, 2024
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
March 11, 2024
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 19, 2023
"Pancreatic Cancer Treatment Market"(Albany, USA) DelveInsight's "Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Pancreatic Cancer, historical and
January 2, 2023
The prevalence of pancreatic cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline
October 29, 2021
Pancreatic Cancer Pipeline is enriched with novel therapeutic strategies, including a broad range of therapies targeting diverse biologic processes. The...